NCDR Study Looks at Real-World Implications of ABSORB II and III Trials: NCDR Study Looks at Real-World Implications of ABSORB II and III Trials

Antithrombotic Strategy in Patients With AF and Recent ACS or PCI: Primary Results of the AUGUSTUS Trial

Vericiguat Improves Outcomes in Patients with Worsening Heart Failure

Placement of Aortic Transcatheter Valves 3 - PARTNER 3

Randomized Clinical Trails regarding IVUS vs. OCT Guided PCI

Should the 10-Year Results From the SYNTAX Trial Redefine Who We Consider for CABG?

Artificial Intelligence in Interventional Cardiology

ESC Consensus on HFpEF Diagnosis: Key Points

Evolving TAVR Populations: Questions and Challenges Remain

Considerations for Optimal Device Selection in TAVR